New drug is first to help patients with recurrent low-grade ovarian cancer
Friday, February 8, 2013 - 16:30
in Health & Medicine
Low-grade serous ovarian cancer is less common and aggressive than the high-grade variety, yet exceptionally difficult to treat when frontline therapy fails.